medigraphic.com
ISSN 0326-3428 (Impreso)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2021, Número 4

<< Anterior Siguiente >>

Rev Nefrol Dial Traspl 2021; 41 (4)


Injuria renal aguda asociada a medios de contraste radiológicos yodados: una mirada actualizada

Herrera P, Wenger R, Aros C, Muñoz D, Ardiles LG

Idioma: Español
Referencias bibliográficas: 28
Paginas: 292-299
Archivo PDF: 259.39 Kb.


RESUMEN

La injuria renal aguda asociada a medios de contraste radiológicos yodados es una entidad clínica cuya real dimensión aún es discutida. La importancia del tipo de medio de contraste y las condiciones predisponentes son discutidas en una revisión actualizada del tema, poniendo énfasis en los factores fisiopatológicos involucrados y las estrategias preventivas más efectivas. Una adecuada valoración clínica permitirá efectuar exámenes complementarios que pueden resultar cruciales para el manejo de los pacientes y evitar el uso de estrategias preventivas innecesarias y potencialmente dañinas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Mehran R, Dangas GD, Weisbord SD. Contrast-Associated acute kidney injury. N Engl JMed. 2019;380(22):2146-55. doi: 10.1056/NEJMra1805256.

  2. Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM,Hilton S, Reese PP. The controversy of contrast-inducednephropathy with intravenous contrast: what is the risk?Am J Kidney Dis. 2020;75(1):105-13. doi: 10.1053/j.ajkd.2019.05.022.

  3. Quader MA, Sumpio BE. Radio contrast agents: historyand evolution. En: CJB, editor. Text of Angiology. NewYork, NY: Springer; 2000, p. 775-83.

  4. Thomsen HS, Vestergaard A, Nielsen SL, Fogh-Andersen N, Golman K, Dorph S. Renal clearanceof an ionic high-osmolar and a nonionic low-osmolarcontrast medium. Invest Radiol. 1991;26(6):564-8. doi:10.1097/00004424-199106000-00011.

  5. Lawaczeck R, Jost G, Pietsch H. Pharmacokineticsof contrast media in humans: model withcirculation, distribution, and renal excretion.Invest Radiol. 2011;46(9):576-85. doi: 10.1097/RLI.0b013e31821c1140.

  6. Beckett KR, Moriarity AK, Langer JM. Safe use ofcontrast media: what the radiologist needs to know.Radiographics. 2015;35(6):1738-50. doi: 10.1148/rg.2015150033.

  7. Munger K, Brenner B, Kost CJ. The renal circulationsand glomerular ultrafiltration. En: Skorecki K, ChertowGM, Marsden PA, Brenner BM, Rector FC. Brennerand Rector´s the Kidney. 10th ed. Philadelphia: Elsevier,2016, pp. 83-111.

  8. Jefferson JA, Schrier RW. Pathophysiology and etiologyof acute kidney injury. En: Johnson RJ, Feehally J,Floege J. Comprehensive clinical nephrology. 5th ed.Philadelphia: Saunders, Elsevier; 2015, pp. 802-17.

  9. Geenen RWF, Kingma HJ, van der Molen AJ.Pathophysiology of contrast-induced acute kidneyinjury. Interv Cardiol Clin. 2014;3(3):363-7. doi:10.1016/j.iccl.2014.03.007.

  10. Pallone TL, Turner MR, Edwards A, Jamison RL.Countercurrent exchange in the renal medulla. Am JPhysiol Regul Integr Comp Physiol. 2003;284(5):R1153-75. doi: 10.1152/ajpregu.00657.2002.

  11. Fähling M, Seeliger E, Patzak A, Persson PB.Understanding and preventing contrast-induced acutekidney injury. Nat Rev Nephrol. 2017;13(3):169-80.doi: 10.1038/nrneph.2016.196.

  12. Weisbord SD, Palevsky PM. Iodinated contrast mediaand the role of renal replacement therapy. Adv ChronicKidney Dis. 2011;18(3):199-206. doi: 10.1053/j.ackd.2010.11.008.

  13. Lautin EM, Freeman NJ, Schoenfeld AH, BakalCW, Haramati N, Friedman AC, et al. Radiocontrastassociatedrenal dysfunction: incidence and risk factors.AJR Am J Roentgenol. 1991;157(1):49-58. doi: 10.2214/ajr.157.1.2048539.

  14. Mehran R, Aymong ED, Nikolsky E, Lasic Z, IakovouI, Fahy M, et al. A simple risk score for prediction ofcontrast-induced nephropathy after percutaneouscoronary intervention: development and initialvalidation. J Am Coll Cardiol. 2004;44(7):1393-9. doi:10.1016/j.jacc.2004.06.068.

  15. 15.) Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA,Yerkey MW, Glazier S, et al. Impact of nephropathyafter percutaneous coronary intervention and a methodfor risk stratification. Am J Cardiol. 2004;93(12):1515-9. doi: 10.1016/j.amjcard.2004.03.008.

  16. Tsai TT, Patel UD, Chang TI, Kennedy KF, MasoudiFA, Matheny ME, et al. Validated contemporary riskmodel of acute kidney injury in patients undergoingpercutaneous coronary interventions: insights fromthe National Cardiovascular Data Registry Cath-PCIRegistry. J Am Heart Assoc. 2014;3(6):e001380. doi:10.1161/JAHA.114.001380.

  17. Liu YH, Liu Y, Zhou YL, He PC, Yu DQ, Li LW, etal. Comparison of different Risk scores for predictingcontrast induced nephropathy and outcomes afterprimary percutaneous coronary intervention inpatients with ST elevation myocardial infarction. AmJ Cardiol. 2016;117(12):1896-903. doi: 10.1016/j.amjcard.2016.03.033.

  18. Silver SA, Shah PM, Chertow GM, Harel S, Wald R,Harel Z. Risk prediction models for contrast inducednephropathy: systematic review. BMJ. 2015;351:h5401.doi: 10.1136/bmj.h5401. Erratum for: BMJ.2015;351:h4395.

  19. Wi J, Ko YG, Shin DH, Kim JS, Kim BK, Choi D,et al. Prediction of contrast-induced nephropathywith persistent renal dysfunction and adverse longtermoutcomes in patients with acute myocardialinfarction using the Mehran risk score. Clin Cardiol.2013;36(1):46-53. doi: 10.1002/clc.22060.

  20. Sato A, Hoshi T, Kakefuda Y, Harunari T, WatabeH, Hiraya D, et al. Effect of the Mehran risk score forthe prediction of clinical outcomes after percutaneouscoronary intervention. J Cardiol. 2015;66(5):417-22.doi: 10.1016/j.jjcc.2014.12.016.

  21. Zungur M, Gul I, Tastan A, Damar E, Tavli T.Predictive value of the Mehran score for contrastinducednephropathy after transcatheter aortic valveimplantation in patients with aortic stenosis. CardiorenalMed. 2016;6(4):279-88. doi: 10.1159/000443936.

  22. Abellás-Sequeiros RA, Raposeiras-Roubín S, Abu-AssiE, González-Salvado V, Iglesias-Álvarez D, Redondo-Diéguez A, et al. Mehran contrast nephropathyrisk score: Is it still useful 10 years later? J Cardiol.2016;67(3):262-7. doi: 10.1016/j.jjcc.2015.05.007.

  23. Valappil SP, Kunjukrishnapillai S, Iype M, KoshyAG, Viswanathan S, Gupta PN, et al. Predictors ofcontrast induced nephropathy and the applicability ofthe Mehran risk score in high risk patients undergoingcoronary angioplasty-A study from a tertiary care centerin South India. Indian Heart J. 2018;70(3):399-404.doi: 10.1016/j.ihj.2017.08.018.

  24. Sgura FA, Bertelli L, Monopoli D, Leuzzi C, Guerri E,Spartà I, et al. Mehran contrast-induced nephropathyrisk score predicts short- and long-term clinicaloutcomes in patients with ST-elevation-myocardialinfarction. Circ Cardiovasc Interv. 2010;3(5):491-8. doi:10.1161/CIRCINTERVENTIONS.110.955310.

  25. Blanco A, Rahim F, Nguyen M, Quach S, GuduruS, Makadia S, et al. Performance of a pre-proceduralMehran score to predict acute kidney injury afterpercutaneous coronary intervention. Nephrology(Carlton). 2021;26(1):23-9. doi: 10.1111/nep.13769.

  26. Khwaja A. KDIGO clinical practice guidelines for acutekidney injury. Nephron Clin Pract. 2012;120(4):c179-84. doi: 10.1159/000339789.

  27. Weisbord SD, Palevsky PM. Contrast-induced acutekidney injury: short- and long-term implications.Semin Nephrol. 2011;31(3):300-9. doi: 10.1016/j.semnephrol.2011.05.009.

  28. Pomara C, Pascale N, Maglietta F, Neri M, RiezzoI, Turillazzi E. Use of contrast media in diagnosticimaging: medico-legal considerations. Radiol Med.2015;120(9):802-9. doi: 10.1007/s11547-015-0549-6.




2020     |     www.medigraphic.com